Vanberra Signal

SOCAR Research

Curated by Signal

Phase I to phase IV clinical trials with proprietary platform e-SOCDAT

Overview

SOCAR Research offers design, management and conduct of phase I to phase IV clinical trials. Their focus is in therapeutic research areas like cardiovascular, cachexia, cerebrovascular, central nervous system, haematology, hypertension, metabolic, nephrology, nutraceuticals, and oncology telemedicine. e-SOCDAT, their propritary product helps in capturing, accessing and streamlining clinical and operational metadata.The company offers services like scientific expertise, monitoring, pharmacovigilance, biostatistics, medical writing, randomization, etc.

Key facts

Founded
1986
Headquarters
Nyon, Switzerland

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of nutrition and consultation services for menopausal disorders

    Health TechnologyVesenaz, Switzerland
  • Develops virtual reality surgical simulators for medical training

    Health TechnologySchlieren, Switzerland
  • Online platform offering diet plans for weight loss management

    Health TechnologyZurich, Switzerland

About SOCAR Research

What does SOCAR Research do?

SOCAR Research offers design, management and conduct of phase I to phase IV clinical trials.

Where is SOCAR Research headquartered?

SOCAR Research is headquartered in Nyon, Switzerland.

When was SOCAR Research founded?

SOCAR Research was founded in 1986.

Which sector is SOCAR Research in?

SOCAR Research operates in Health Technology.

Who are SOCAR Research's competitors?

Companies similar to SOCAR Research include Ma Positive Attitude, VirtaMed, and eBalance.